Contrast Media Agents Market is expected to reach US$ 6,860.6 Mn and estimated to grow with a CAGR of 4.0% Till 2027 With General Electric, Bayer AG, Bracco, Guerbet, Lanthus Medical Imaging Inc., nanoPET Pharma GmbH, Unijules Life Sciences Ltd.,And Other

The Covid-19 (coronavirus) pandemic is impacting society and the overall economy across the world. The impact of this pandemic is growing day by day as well as affecting the supply chain. The COVID-19 crisis is creating uncertainty in the stock market, massive slowing of supply chain, falling business confidence, and increasing panic among the customer segments. The overall effect of the pandemic is impacting the production process of several industries including Life science Industry, and many more. Trade barriers are further restraining the demand- supply outlook. As government of different regions have already announced total lockdown and temporarily shutdown of industries, the overall production process being adversely affected; thus, hinder the overall Contrast Media Agents market globally. This report on ‘Contrast Media Agents market’ provides the analysis on impact on Covid-19 on various business segments and country markets. The report also showcase market trends and forecast to 2027, factoring the impact of Covid -19 Situation.

Get the inside scope of the Sample report @ https://www.theinsightpartners.com/sample/TIPHE100001102/?Openpr-10225

According to The Insight Partners market research study titled ‘Contrast Media Agents Market to 2027 – Global Analysis and Forecasts by Type, Imaging Modality, Indication, Route of Administration and Geography. The Global Contrast Media Agents Market is expected to reach US$ 6,860.6 Mn in 2027 from US$ 4,855.2 Mn in 2018. The market is estimated to grow with a CAGR of 4.0% from 2019-2027. The report highlights the trends prevalent in the global contrast media agents market and the factors driving the market along with those that act as challenges to its growth.

Company Profiles

General Electric
Bayer AG
Bracco
GUERBET
Lantheus Medical Imaging, Inc.
nanoPET Pharma GmbH
Unijules Life Sciences Ltd.
Magnus Health Management Pvt Ltd.
J.B.Chemicals and Pharmaceuticals Ltd.
Jodas Expoim

Market Insights

Developments in Diagnostic Imaging Modalities Coupled with Rising Number of Diagnostic Tests Procedures

Medical imaging has become essential to medical care and treatment across the globe. Rising awareness regarding early diagnosis of diseases have led to increase in the total number of diagnostic tests procedures performed across the globe. In 2012, Canadians underwent 1.7 million magnetic resonance imaging (MRI) exams and 4.4 million computed tomography (CT) exams. This represents nearly double the number of such exams performed in 2003. In 2014-15, the national rate for CT scans was 126 per 1,000 people. Rates ranged from highs of 209 (New Brunswick) and 170 (Newfoundland and Labrador) to lows of 88 (Alberta) and 93 (Prince Edward Island). Moreover, according to the National Health Services (NHS) UK, there were 4.1 million imaging tests reported in England in the 12 months from February 2016 to January 2017. Of these, 3.49 million imaging tests were reported to have taken place in January 2017.

Growth Opportunities in The Developing Nations

The number of chronic non-communicable disease are rising across the globe, the prevalence is significantly rising among the developing nations across the globe. The incidences are rising due to the shift in the lifestyle and the other health conditions sue to the change in the adoption of the modernized facilities. The modernized facilities reduced the physical activities, the stress level among the people are also rising. This is expected to be a leading factor to support rising demand for the contrast media agents, with generating patient awareness regarding taking preventive measures as well as benefits of early diagnosis. The developing nations are significantly developing their healthcare facilities and services and are heading towards the technological advancements. With increasing costs of manufacturing against their practices, the medical device manufacturers are struggling to generate enough revenue to please their investors. The emerging markets in the developing economies are expected to be the crucial factor offering better and lucrative growth opportunities for the major players to expand their business and geographic reach.

Strategic Insights

Organic and inorganic growth strategies were observed in global contrast media agents industry. For instance, in April, 2019, Lantheus Medical Imaging, Inc. entered into a strategic collaboration with Cerevast Medical, Inc. identify new applications for its microbubble franchise and expand into new disease areas, such as ocular diseases. Thus, the inorganic strategy has enabled the company to grow its business in the market.

Contrast Media Agents – MARKET SEGMENTATION

By Type

Iodinated Contrast Media
Gadolinium Based Contrast Media
Barium Based Contrast Media
Microbubble Contrast Media

By Imaging Modality

X-Ray/CT
Magnetic Resonance Imaging
Ultrasound

By Indication

Cardiovascular Disorders
Cancer
Gastrointestinal Disorders
Musculoskeletal Disorders
Neurological Disorders
Nephrological Disorders

By Route of Administration

Intravascular
Oral
Rectal

By Geography
North America
Europe
Asia Pacific (APAC)
Middle East & Africa (MEA)
South America (SAM)

TOC of Market Report Contains:

Industry Overview
Production Market Analysis
Sales Market Analysis
Consumption Market Analysis
Production, Sales and Consumption Market Comparison Analysis
Major Manufacturers Production and Sales Market Comparison Analysis
Major Type of Analysis
Major Organization Size Analysis
Industry Chain Analysis
Global and Regional Market Forecast
Major Manufacturers Analysis
New Project Investment Feasibility Analysis
And More…

Reasons To Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Click to buy full report with all description: https://www.theinsightpartners.com/buy/TIPHE100001102/?Openpr-10225

Contact Us:
The Insight Partners,
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.
We understand syndicated reports may not meet precise research requirements of all our clients. We offer our clients multiple ways to customize research as per their specific needs and budget

This release was published on openPR.